Mauna Kea Technologies SA (FRA:1MK)

Market Cap	20.05M +134.0%
Revenue (ttm)	8.38M +2.4%
Net Income	10.63M
EPS	n/a
Shares Out	n/a
PE Ratio	2.09
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	143,298
Open	0.1038
Previous Close	0.1148
Day's Range	0.1038 - 0.1038
52-Week Range	0.0505 - 0.2140
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 8, 2026

About Mauna Kea Technologies

Mauna Kea Technologies SA manufactures and sells medical devices in Europe, Middle East, Africa, the United States, Canada, and Asia. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables physicians to monitor disease progression over time, assess reactions as they occur, classify areas of uncertainty, and guide surgical procedures, and help diagnose and treat patients. The company was incorporated in ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2000
• Employees: 59
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1MK

Financial Performance

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 13, 2026

Data Sources Report a data error